What is she best known for?
The fields of study she is best known for:
- Gene
- Immune system
- Antibody
Ada M. Kruisbeek mostly deals with Molecular biology, T cell, T-cell receptor, Cell biology and Cytotoxic T cell.
Her Molecular biology research is multidisciplinary, incorporating elements of Gene rearrangement and Thymocyte, T lymphocyte, CD8, Antigen.
Her specific area of interest is T cell, where Ada M. Kruisbeek studies Interleukin 21.
Her Interleukin 21 study deals with the bigger picture of Immunology.
Ada M. Kruisbeek interconnects Receptor and CD3 in the investigation of issues within T-cell receptor.
Her study in Antigen-presenting cell and CD28 are all subfields of Cytotoxic T cell.
Her most cited work include:
- Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells (810 citations)
- E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements (692 citations)
- Defects in cardiac outflow tract formation and pro-B-lymphocyte expansion in mice lacking Sox-4 (407 citations)
What are the main themes of her work throughout her whole career to date?
Her main research concerns T cell, Immunology, Molecular biology, Cell biology and Cytotoxic T cell.
The various areas that Ada M. Kruisbeek examines in her T cell study include Internal medicine and CD8, Antigen.
Her research in Molecular biology intersects with topics in Interleukin 2, Cell culture, Antibody and Lymphocyte.
Her Cell biology research focuses on Cellular differentiation and how it relates to B cell.
Antigen-presenting cell, Interleukin 21, IL-2 receptor, Streptamer and CD28 are the subjects of her Cytotoxic T cell studies.
Her work carried out in the field of T-cell receptor brings together such families of science as Receptor, CD3, Thymocyte and Alpha.
She most often published in these fields:
- T cell (44.36%)
- Immunology (42.86%)
- Molecular biology (35.34%)
What were the highlights of her more recent work (between 2003-2018)?
- Immunology (42.86%)
- T cell (44.36%)
- Cytotoxic T cell (30.83%)
In recent papers she was focusing on the following fields of study:
Ada M. Kruisbeek mainly focuses on Immunology, T cell, Cytotoxic T cell, Immunotherapy and Myeloid leukemia.
Her Epitope and Experimental autoimmune encephalomyelitis study, which is part of a larger body of work in Immunology, is frequently linked to Off the shelf, bridging the gap between disciplines.
Her T cell research is multidisciplinary, incorporating perspectives in CD8 and Lymph node.
Her biological study spans a wide range of topics, including Cancer vaccine and T-cell receptor.
Her research in the fields of Interleukin 21 overlaps with other disciplines such as Repertoire.
Her Interleukin 21 research incorporates elements of CD40, Antigen-presenting cell, Lymphocytic choriomeningitis, Vesicular stomatitis virus and Cell biology.
Between 2003 and 2018, her most popular works were:
- C-type lectin-like molecule-1: A novel myeloid cell surface marker associated with acute myeloid leukemia (158 citations)
- Proliferative assays for T cell function. (117 citations)
- Immunological and Antitumor Effects of IL-23 as a Cancer Vaccine Adjuvant (75 citations)
In her most recent research, the most cited papers focused on:
- Gene
- Immune system
- Antibody
Her primary areas of study are T cell, Molecular biology, Cytotoxic T cell, Interleukin 21 and Immunology.
Her T cell study incorporates themes from Immunotherapy, Antigen and Vaccination.
Her Molecular biology study which covers Phage display that intersects with Flow cytometry and Direct fluorescent antibody.
The Cytotoxic T cell study combines topics in areas such as Spleen, Multiple sclerosis, Proteolipid protein 1 and Cell biology.
Her Interleukin 21 research is multidisciplinary, incorporating elements of IL-2 receptor, CD40, Antigen-presenting cell, Natural killer T cell and Experimental autoimmune encephalomyelitis.
Her study in the field of Adjuvant, CD8, Cancer vaccine and Peptide vaccine also crosses realms of Proinflammatory cytokine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
